Effects of two types of prebiotics on the intestinal environment and the antibody titers in patients receiving enteral tube feeding: an open-label, randomised controlled trial

Effects of two types of prebiotics on the intestinal environment and the antibody titers in patients receiving enteral tube feeding: an open-label, randomised controlled trial - Effects of two types of prebiotics on the intestinal environment and acquired immunity

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009832

Enrollment

Registered

2013-01-25

Start date

2008-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza, diarrhea, constipation

Interventions

C group

patients receiving a standard enteral formula for 10 weeks F group

patients receiving BGS, galactooligosaccharides and an acidic enteral formula containing lactic-acid-bacteria-fermented ingredients for 10weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hospitalized patients receiving enteral feeding in Fukushimura Hospital

Exclusion criteria

Exclusion criteria: 1. patients with gastrointestinal disorders such as irritable bowel syndrome and inflammatory bowel disease, or patients with immune diseases, and diabetics 2. other patients judged as inappropriate for the study by the physician in charge

Design outcomes

Primary

Measure	Time frame
antibody titers after influenza vaccination	—

Secondary

Measure	Time frame
microflora and stool form consistency during the study period	—

Countries

Japan

Contacts

Public ContactHiroyasu Akatsu

Fukushimura Hospital Choju Medical Institute

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026